Catalyst Pharmaceuticals (CPRX) Gross Profit Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 16.94% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,488.21% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 9.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.23% |
| Dec 31, 2025 | 5.29% |
| Sep 30, 2025 | 14.92% |
| Jun 30, 2025 | 17.37% |
| Mar 31, 2025 | 43.63% |
| Dec 31, 2024 | 26.82% |
| Sep 30, 2024 | 23.61% |
| Jun 30, 2024 | 22.58% |
| Mar 31, 2024 | 14.01% |
| Dec 31, 2023 | 91.19% |
| Sep 30, 2023 | 86.05% |
| Jun 30, 2023 | 92.52% |
| Mar 31, 2023 | 102.75% |
| Dec 31, 2022 | 60.08% |
| Sep 30, 2022 | 55.26% |
| Jun 30, 2022 | 42.90% |
| Mar 31, 2022 | 45.74% |
| Dec 31, 2021 | 18.42% |
| Sep 30, 2021 | 20.47% |
| Jun 30, 2021 | 24.96% |
| Mar 31, 2021 | 2.15% |
| Dec 31, 2020 | 1.64% |
| Sep 30, 2020 | -4.04% |
| Jun 30, 2020 | 3.62% |
| Mar 31, 2020 | 132.72% |